Objective: To examine 5-year trajectories of psychiatrist-treated late-life major depressive disorder (MDD), and evaluate whether previous vascular pathology is associated with more severe trajectories of late-life MDD. Methods: Data were obtained from nationally representative civil, psychiatric, hospital and prescription registers in Denmark. The sample included 11,092 older adults (≥60 years) who received their first diagnosis of MDD in a psychiatric facility in Denmark between 2000 and 2007. Trajectories of in-or outpatient contact at psychiatric hospitals for MDD over the 5-year period following index MDD diagnosis were modeled using latent class growth analysis. Measures of vascular disease (stroke, heart disease, vascular dementia) and vascular risk factors (hypertension, diabetes) were defined based on medication prescriptions and hospital-based diagnoses. Other predictors included demographic characteristics and characteristics of the index MDD diagnosis.
INTRODUCTION
There is reason to believe that depression occurring in late life may be a distinct clinical and/or etiological entity from earlier-onset depression. Epidemiological studies using both register-based (1) and community (2) samples find that the age of onset distribution of major depressive disorder (MDD) is bimodal, with one peak in early adulthood and a second, smaller peak in older adulthood. This suggests that individuals are at increased risk for developing MDD at two very different points in the lifespan. Studies also suggest that late-onset depression may have a smaller genetic component than earlier onset depression (3, 4) , which implies that environment or lifestyle factors play a larger role in precipitating late-life MDD. One welldeveloped hypothesis regarding the etiology of late-life depression is the vascular depression hypothesis (5) (6) (7) (8) (9) , which posits that vascular pathologies can lead to white matter lesions in the brain that "predispose, precipitate or perpetuate a depressive syndrome in many elderly patients" (Alexopoulos et al., 1997, pg. 915 ). According to this hypothesis, vascular pathology can both precipitate the onset of depression among older adults with no previous depression episodes, and precipitate recurrent episodes among older adults with a prior history of MDD (8) . Consistent with this hypothesis, studies have demonstrated that MDD is more common among individuals who have had a stroke (10) , and that late-onset MDD is associated with increased risk for vascular disease in relatives (11) .
Evidence suggests that vascular pathology may be associated with more severe long-term trajectories of depressive symptoms in general population samples of older adults. Byers and colleagues (12) found that stroke, hypertension and diabetes were associated with high and increasing 20-year depressive symptom trajectories in older women. Kooistra found that cerebrovascular disease in particular was associated with symptom chronicity. These studies support the idea that vascular pathology may perpetuate depressive symptoms among older adults. However, it is unclear to what extent this association pertains to trajectories of clinically diagnosed MDD.
Our goal in this study was twofold: first, we aimed to characterize trajectories of clinically diagnosed late-life MDD in a sample of older adults treated in secondary psychiatric care. To accomplish this, we used information from the Danish Central Psychiatric Research Register (DCPRR), which includes records of all inpatient and outpatient treatment in psychiatric hospitals in Denmark. As the vast majority of psychiatric treatment in Denmark is provided by the public sector, this register provides a highly comprehensive view of users of the secondary psychiatric treatment system (1) . Second, we aimed to evaluate whether a prior diagnosis with vascular disease or vascular risk factors predicts the course trajectory of secondary-treated latelife MDD. We hypothesized that individuals with a history of vascular disease or vascular risk factors would be more likely to experience a chronic course.
METHODS

Data Sources
Data for this study were obtained from the following Danish national registers: the Danish Civil Registration System [DCRS] (14, 15) , the DCPRR (16) 
Measures
Vascular pathology. We examined five different forms of vascular pathology, including two vascular risk factors (hypertension, diabetes) and three forms of vascular disease (stroke, heart disease, vascular dementia). Information on these five types of vascular pathology was obtained from the DNPR, DNPreR and, for vascular dementia, also the DPCRR. Individuals were considered to have a history of a given form of vascular pathology if they either a) were treated in a somatic hospital with a primary, secondary or 'underlying cause' diagnosis of that pathology during the 5-year period preceding their index MDD diagnosis or b) filled a prescription from their GP for a medication used to treat that pathology during the same period.
ICD-10 and Anatomical Therapeutic Chemical (ACT) codes used to define the different types of vascular pathology are listed in Supplemental Table 1 . ICD-10 and ACT codes were selected based on prior research using the Danish registers (21) (22) (23) . Each form of vascular pathology was operationalized as a dichotomous variable, with a score of 1 indicating that the individual had received a diagnosis of, or been prescribed medication for, that type of vascular pathology during the 5-year period preceding his or her index MDD diagnosis. The variables were not mutually exclusive. Given that vascular risk factors and disease frequently co-occur and affect depression via similar biological mechanisms (24), we also created a measure of vascular burden equal to the number (0-5) of vascular diagnoses received by each individual during the 5-year period prior to his or her index MDD diagnosis. 
Analytic design and statistical methods
We assessed vascular pathology during the 5-year period before each individual's index MDD diagnosis. We then modeled trajectories of MDD during the subsequent 5-year period following the index MDD diagnosis (See Figure 2 ). Trajectories were modeled using latent class growth analysis [LCGA] (25, 26) in SAS PROC TRAJ (27, 28) . The primary response variable was in-or outpatient psychiatric contact (yes/no) with a primary diagnosis of MDD during each 6-month interval in the 5-year period following the index MDD diagnosis.
In LCGA, the optimal number of classes is determined by fitting models with different numbers of classes and comparing fit statistics (25, 26) . We fit models with 1-7 classes, but the 7class model would not converge. We allowed for non-linearity of trajectories by including up to cubic polynomial terms for each class in each model. If a term was not significant (p<.05), or if the model failed to converge, we refit the model with quadratic or linear terms. Not surprisingly given the age of the sample, attrition due to death during the 5-year follow-up period was high (37.5%). To avoid bias due to non-random participant attrition (29), we incorporated a dropout model in which the probability of death at each time point was allowed to depend on the previous two time periods, age at index MDD diagnosis, inpatient treatment and somatic illness (vascular pathology and cancer) during the 5 years before index MDD diagnosis.
After selecting the final number of classes, we fit LCGA models in PROC TRAJ that included a structural component (i.e., a multinomial regression with class membership as the outcome variable) to assess the effects of different measures of vascular pathology on the odds of trajectory class membership. The largest class was used as the reference category. We present results from two conditional LCGA models: one which included the 5 individual measures of vascular pathology, and one which included our aggregate measure of vascular burden. This 'one-step approach' accounts for uncertainty in class assignment because the two parts of the model (the structural component and the measurement component) are estimated simultaneously (30) . Both models were adjusted for sex, birthplace, age, severity, inpatient vs. outpatient treatment, number of months on antidepressant medication, and calendar year at index MDD diagnosis.
Sensitivity analyses
To assess whether it is the experience of having a serious somatic illness, rather than vascular pathology per se, that influences trajectories of late-life MDD, we also examined the impact of a cancer diagnosis (ICD-10 codes C00-C97) within the 5-year period preceding the index MDD diagnosis.
RESULTS
Model selection
When selecting the final model, we took into consideration AIC and BIC values ( 
Trajectories of late-life MDD
Five-year trajectories of secondary-treated late-life MDD are shown in Figure 3 consistently high classes, such that as severity increased, the odds of membership increased from a 1.33-1.41 fold increase for moderate MDD to a 2.39-2.82 fold increase for severe MDD with psychotic features. The association between severity and membership in the moderate fluctuating class was less pronounced; moderate MDD did not significantly increase the odds of membership in the class, and the increase in odds associated for severe (1. 68 [1.19 
Sensitivity analysis
A cancer diagnosis during the 5-year period prior to the index MDD diagnosis was not significantly associated with trajectory class membership (data not shown).
DISCUSSION
The goals of this study were to characterize 5-year trajectories of secondary-treated latelife MDD using data from Danish national registers, and examine the extent to which vascular disease and vascular risk factors are associated with different trajectories among older secondary-treated MDD patients. Latent class growth analysis yielded a 4-class model with the following groups: consistently low (66% of the sample) probability of subsequent secondary care for MDD during the 5-year period following the index MDD diagnosis, high decreasing probability (19%), consistently high probability (9%) and moderate fluctuating probability (6%).
Older age, greater severity of the index MDD episode and > 12 months of antidepressant medication use in the 5-year period preceding the first MDD diagnosis in secondary care were associated with increased odds of membership in the high decreasing, consistently high and moderate fluctuating classes relative to the consistently low class. We found no significant associations between any form of vascular pathology and trajectory of secondary-treated late-life MDD.
Consistent with previous studies (32, 33) , our findings suggest that a substantial proportion of older MDD patients experience persistent or recurring MDD over extended periods of time: 34% of the individuals in our sample were in secondary treatment with a primary diagnosis of MDD at various periods and for various lengths of time during the 5-year period following their index MDD diagnosis. Additional members of the sample may have experienced subclinical depressive symptoms that did not bring them back into secondary treatment. These findings highlight the burden of MDD among the elderly, and reaffirm that this population, particularly those who enter the secondary treatment system at an older age, with a more severe clinical presentation and recent prolonged antidepressant medication use, requires special attention from clinicians and policymakers.
Our hypothesis that pre-existing vascular pathology would be associated with greater chronicity in 5-year course trajectories of clinically diagnosed MDD in older adults was not supported. There is substantial evidence demonstrating an association between, for example, stroke and the incidence or prevalence of depression (see Robinson & Jorge, 2015 for a review), including evidence from Danish registers (34) . However the evidence suggesting an association between vascular pathology and chronicity of depression is less robust. The most widely documented and heavily researched findings in this area suggest differences in executive function and cognitive impairment among patients with so-called vascular depression (8) .
Although some research found that executive dysfunction was associated with relapse and recurrence (35) others found no such effect (36) . It is possible, therefore, that while vascular pathology is associated with the occurrence of MDD, it has less of an impact on the course of illness after the initial syndrome has converted to onset meeting complete diagnostic criteria. A second interpretation of these findings is that vascular pathologies may contribute to differences in the course of depressive symptoms as suggested previously (12, 13, 37) , but not in a way that translates into differences in long-term contact patterns with the secondary psychiatric treatment system. For example, vascular pathology may increase the chronicity of subclinical depressive symptoms (12, 13) , which either go untreated or are more likely to be treated solely in a primary care setting.
Methodological considerations
Several important methodological features should be taken into account when interpreting these results. First, we were unable to examine the impact of all vascular risk factors because the registers do not include information on diet, physical activity, obesity or smoking.
Second, individuals who did not receive MDD treatment, or received only medication management via their primary care doctors, were not included in our analyses. Our research goal was to examine trajectories of MDD treated in specialty psychiatric settings. Because the majority of secondary psychiatric care in Denmark is provided by the public sector, and all psychiatric treatment in the public sector is recorded in the registry, we are confident that our sample is representative of this population. However, it should be noted that our results may not necessarily generalize to all individuals with MDD.
Third, we could not distinguish in this study between truly first-onset MDD cases and individuals experiencing recurrent MDD episodes. Because this was an older sample, and the DCPRR only includes records of inpatient visits since 1969 and outpatient visits since 1995, we can only be sure these individuals had not received treatment from a psychiatrist within the past 5 years. According to the vascular depression hypothesis, vascular pathology could theoretically precipitate either a first-onset or a recurrent MDD episode (8) , however it is unclear to what, if any, extent it might influence subsequent course trajectories differently for first-onset vs. recurrent MDD cases. Further research is needed to investigate this issue.
Fourth, we were unable to measure depressive symptoms directly, or to account for other factors influencing secondary treatment such as adherence to doctor recommendations. It should be noted that the dates on which individuals enter and exit secondary treatment do not correspond perfectly with the onset or remission of depressive symptoms; as our own data attest, nearly 90% of individuals in our sample received a prescription for antidepressants before their index diagnosis, indicating they were already experiencing symptoms. Denmark has a gatekeeper healthcare system in which individuals seek care first from their primary care doctors and are then referred for specialty care if needed, therefore this pattern was expected.
Finally, it is worth noting that vascular pathology was more common among individuals who died during the 5-year follow-up period compared to individuals who survived for at least 5 years following their index MDD diagnosis. Although we fit a conditional dropout model as part of our trajectory analysis, this may not have entirely eliminated bias due to differential attrition.
In addition, the 1,016 older adults with late-life MDD who were excluded because they died within 6 months of receiving their index MDD diagnosis were also significantly more likely than individuals included in the study sample to have prior cerebrovascular disease across all categories except for vascular dementia. Therefore, there may have been some bias created by Trajectories of Late Life Depression 18 the fact that the individuals included in our analyses were less likely than the population of older adults with late-life MDD overall to have cerebrovascular disease.
Conclusions
A notable proportion (34%) of older adults diagnosed with MDD in a secondary care setting require specialized psychiatric treatment for extended periods of time. These individuals tend to be older and have a more severe clinical presentation at index MDD diagnosis than individuals with a better prognosis. We found no evidence that vascular pathology during the 5-
year period prior to the index MDD diagnosis was associated with differences in the subsequent course trajectory of psychiatric hospital contacts for MDD in older patients. 
